Clinical Trials Directory

Trials / Completed

CompletedNCT01512082

The Effect of Reducing Soreness in Marathon Runners

The Effect of Pulsed Electromagnetic Field Therapy in Reducing Delayed Onset Muscle Soreness in Marathon Runners. A Double-blind Randomized Placebo-controlled Study.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
47 (actual)
Sponsor
Northern Orthopaedic Division, Denmark · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Delayed onset muscle soreness is defined as the sensition of pain and discomfort in skeletal muscles that occurs after eccentric muscle actions or strenuous exercise like a marathon.

Detailed description

There is a growing body of clinical evidence which shows that noninvasive, nonpharmacologic pulsed electromagnetic fields have many clinical effects. Pulsed electromagnetic fields have shown to reduce pain in different groups of patients. This concerns patients with osteoarthritis, rheumatoid arthritis, diabetic neuropathy, fibromyalgia, distal radius fractures, pelvic pain and postoperative patients. A marathon is a muscular strain. Physiologic effects of a marathon involves muscular and connective tissue damage which initiates an inflammatory response as well as release of metabolic factors like lactate and free radicals, intracellular metabolites and by-products of proteolysis. The objective of this study was to investigate the efficacy of pulsed electromagnetic fields compared to placebo in reducing delayed onset muscle soreness in marathon runners.

Conditions

Interventions

TypeNameDescription
DEVICEPulsed electromagnetic field devicesEvery person received two active devices. The devices emitted 2-ms bursts of 27.12 MHz sinusoidal waves repeating at 2 bursts/s. Peak magnetic field intensity was 0.05 G which induced an average electric field of 10 mV in the tissue with an effect of 7.3 mW/cm3.
DEVICEPulsed electromagnetic field devicesEvery persons received two sham pulsed electromagnetic field devices.

Timeline

Start date
2011-08-01
Primary completion
2012-05-01
Completion
2012-05-01
First posted
2012-01-19
Last updated
2015-04-10

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01512082. Inclusion in this directory is not an endorsement.